Immunogen IMGN reported its Q3 earnings results on Friday, October 29, 2021 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Immunogen reported in-line EPS of $-0.18 versus an estimate of $-0.18.
Revenue was up $8,979,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03, which was followed by a 0.71% drop in the share price the next day.
Here's a look at Immunogen's past performance:
Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
---|---|---|---|---|
EPS Estimate | -0.18 | -0.19 | -0.08 | -0.18 |
EPS Actual | -0.15 | -0.17 | 0.16 | -0.13 |
Revenue Estimate | 18.92M | 17.73M | 40.83M | 15.36M |
Revenue Actual | 16.95M | 15.71M | 85.80M | 18.19M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in